These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17230065)

  • 1. A strategy for controlling potential interactions between natural health products and chemotherapy: a review in pediatric oncology.
    Seely D; Stempak D; Baruchel S
    J Pediatr Hematol Oncol; 2007 Jan; 29(1):32-47. PubMed ID: 17230065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community identification of natural health product-drug interactions.
    Charrois TL; Hill RL; Vu D; Foster BC; Boon HS; Cramer K; Vohra S
    Ann Pharmacother; 2007 Jul; 41(7):1124-9. PubMed ID: 17578882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural health product-drug interactions: evolving responsibilities to take complementary and alternative medicine into account.
    Gilmour J; Harrison C; Asadi L; Cohen MH; Vohra S
    Pediatrics; 2011 Nov; 128 Suppl 4():S155-60. PubMed ID: 22045857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural health product use in Canada: analysis of the National Population Health Survey.
    Singh SR; Levine MA
    Can J Clin Pharmacol; 2006; 13(2):e240-50. PubMed ID: 16921199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting angiogenesis with integrative cancer therapies.
    Yance DR; Sagar SM
    Integr Cancer Ther; 2006 Mar; 5(1):9-29. PubMed ID: 16484711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported use of natural health products: a cross-sectional telephone survey in older Ontarians.
    Levine MA; Xu S; Gaebel K; Brazier N; Bédard M; Brazil K; Lohfeld L; MacLeod SM
    Am J Geriatr Pharmacother; 2009 Dec; 7(6):383-92. PubMed ID: 20129259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline.
    Landier W; Bhatia S; Eshelman DA; Forte KJ; Sweeney T; Hester AL; Darling J; Armstrong FD; Blatt J; Constine LS; Freeman CR; Friedman DL; Green DM; Marina N; Meadows AT; Neglia JP; Oeffinger KC; Robison LL; Ruccione KS; Sklar CA; Hudson MM
    J Clin Oncol; 2004 Dec; 22(24):4979-90. PubMed ID: 15576413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric natural health products recommended by chiropractic and naturopathic doctors in Canada.
    Porcino AJ; Solomonian L; Zylich S; Doucet C; Gluvic B; Vohra S
    Complement Ther Med; 2019 Apr; 43():196-200. PubMed ID: 30935530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herbs or natural products that increase cancer growth or recurrence. Part two of a four-part series.
    Montbriand MJ
    Oncol Nurs Forum; 2004 Sep; 31(5):E99-115. PubMed ID: 15378107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral drug disposition and natural health products: risk of therapeutic alteration and resistance.
    MacDonald L; Murty M; Foster BC
    Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):563-78. PubMed ID: 19442034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary and alternative therapies in pediatric oncology.
    Sencer SF; Kelly KM
    Pediatr Clin North Am; 2007 Dec; 54(6):1043-60; xiii. PubMed ID: 18061790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary and alternative medical therapies used by children with cancer treated at an Italian pediatric oncology unit.
    Clerici CA; Veneroni L; Giacon B; Mariani L; Fossati-Bellani F
    Pediatr Blood Cancer; 2009 Oct; 53(4):599-604. PubMed ID: 19492321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of alternative medicine by children with cancer in Washington state.
    Neuhouser ML; Patterson RE; Schwartz SM; Hedderson MM; Bowen DJ; Standish LJ
    Prev Med; 2001 Nov; 33(5):347-54. PubMed ID: 11676573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary and alternative therapy use in pediatric oncology patients with failure of frontline chemotherapy.
    Paisley MA; Kang TI; Insogna IG; Rheingold SR
    Pediatr Blood Cancer; 2011 Jul; 56(7):1088-91. PubMed ID: 21360653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer patients' behaviors and attitudes toward natural health products.
    Schils A; Lechon AS; Rondeaux S; Souard F; Van Laethem JL; Pochet S; Mathieu V; De Vriese C
    BMC Complement Med Ther; 2023 Dec; 23(1):442. PubMed ID: 38057795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions and attitudes of clinical oncologists on complementary and alternative medicine: a nationwide survey in Japan.
    Hyodo I; Eguchi K; Nishina T; Endo H; Tanimizu M; Mikami I; Takashima S; Imanishi J
    Cancer; 2003 Jun; 97(11):2861-8. PubMed ID: 12767101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of complementary and alternative medicine by pediatric patients with functional and organic gastrointestinal diseases: results from a multicenter survey.
    Vlieger AM; Blink M; Tromp E; Benninga MA
    Pediatrics; 2008 Aug; 122(2):e446-51. PubMed ID: 18662934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural products for chemopreventive and adjunctive therapy in oncologic disease.
    Dennis T; Fanous M; Mousa S
    Nutr Cancer; 2009; 61(5):587-97. PubMed ID: 19838932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials in integrative therapies.
    Barton DL; Pachman DR
    Semin Oncol Nurs; 2012 Feb; 28(1):10-28. PubMed ID: 22281307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential interactions of drug-natural health products and natural health products-natural health products among children.
    Goldman RD; Rogovik AL; Lai D; Vohra S
    J Pediatr; 2008 Apr; 152(4):521-6, 526.e1-4. PubMed ID: 18346508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.